Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
Sponsor: American Diabetes Association
A observational or N/A phase clinical study on Ataxia and Deafness, this trial is actively recruiting participants. The trial is conducted by American Diabetes Association and has accumulated 18 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
18 versions recorded-
Jan 2026 — Present [monthly]
Recruiting
-
Sep 2025 — Jan 2026 [monthly]
Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Recruiting
▶ Show 13 earlier versions
-
Jun 2023 — Jul 2024 [monthly]
Recruiting
-
Jun 2022 — Jun 2023 [monthly]
Recruiting
-
Dec 2021 — Jun 2022 [monthly]
Recruiting
-
May 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — May 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Apr 2020 — Nov 2020 [monthly]
Recruiting
-
Mar 2019 — Apr 2020 [monthly]
Recruiting
-
Jun 2018 — Mar 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Jul 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- American Diabetes Association
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institutes of Health (NIH)
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .